EUVIMEDEUVIMED entdecken
Open Access

Medicaid expansion, chemotherapy delays, and racial disparities among women with early-stage breast cancer

Mariana Chavez-MacGregor iD, Xiudong Lei iD, Catalina Malinowski iD, Hui Zhao iD, Ya-Chen Shih iD, Sharon H Giordano iD

JNCI: Journal of the National Cancer Institute · 2023

DOI: 10.1093/jnci/djad033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2023. Verfasst von Mariana Chavez-MacGregor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services Research, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Hou…. Hauptthemen laut MEDLINE: Breast Neoplasms, Medicaid, Healthcare Disparities. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, Susan G. Komen Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Medicaid expansion under the Affordable Care Act extends eligibility for participating states and has been associated with improved outcomes by facilitating access to care. Delayed initiation of adjuvant chemotherapy is associated with worse outcomes among patients with early-stage breast cancer (BC). The impact of Medicaid expansion in narrowing delays by race and ethnicity has not been studied, to our knowledge.

Methods

This was a population-based study using the National Cancer Database. Patients diagnosed with primary early-stage BC between 2007 and 2017 residing in states that underwent Medicaid expansion in January 2014 were included. Time to chemotherapy initiation and proportion of patients experiencing chemotherapy delays (>60 days) were evaluated using difference-in-difference and Cox proportional hazards models in preexpansion and postexpansion periods according to race and ethnicity.

Results

A total 100 643 patients were included (63 313 preexpansion and 37 330 postexpansion). After Medicaid expansion, the proportion of patients experiencing chemotherapy initiation delay decreased from 23.4% to 19.4%. The absolute decrease was 3.2, 5.3, 6.4, and 4.8 percentage points (ppt) for Black, Hispanic, White, and Other patients. Compared with White patients, statistically significant adjusted difference-in-differences were observed for Black (−2.1 ppt, 95% confidence interval [CI] = −3.7% to −0.5%) and Hispanic patients (−3.2 ppt, 95% CI = −5.6% to −0.9%). Statistically significant reductions in time to chemotherapy between expansion periods were observed among White patients (adjusted hazard ratio = .11, 95% CI = 1.09 to 1.12) and those belonging to racialized groups (adjusted hazard ratio = 1.14, 95% CI = 1.11 to 1.17).

Conclusions

Among patients with early-stage BC, Medicaid expansion was associated with a reduction in racial disparities by decreasing the gap in the proportion of Black and Hispanic patients experiencing delays in adjuvant chemotherapy initiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMedicaidHealthcare DisparitiesFemaleHumansChemotherapy, AdjuvantInsurance CoveragePatient Protection and Affordable Care ActUnited StatesWhiteBlack or African AmericanHispanic or Latino

Autor:innen und Institutionen

  • Department of Health Services Research, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Breast Cancer Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

ORCID-Profile: Mariana Chavez-MacGregor, Xiudong Lei, Catalina Malinowski, Hui Zhao, Ya-Chen Shih, Sharon H Giordano

Förderung

  • NCI NIH HHS
  • NIH HHS
  • Susan G. Komen Foundation
  • National Cancer Institute
  • National Institutes of Health
  • The Breast Cancer Research Foundation
  • ASCO Foundation

Zitieren

APA

Chavez-MacGregor, M., Lei, X., Malinowski, C., Zhao, H., Shih, Y. C., & Giordano, S. H. (2023). Medicaid expansion, chemotherapy delays, and racial disparities among women with early-stage breast cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djad033

Vancouver

Chavez-MacGregor M, Lei X, Malinowski C, Zhao H, Shih YC, Giordano SH. Medicaid expansion, chemotherapy delays, and racial disparities among women with early-stage breast cancer. JNCI: Journal of the National Cancer Institute. 2023. doi:10.1093/jnci/djad033

BibTeX
@article{ChavezMacGregor2023,
  author = {Chavez-MacGregor, Mariana and Lei, Xiudong and Malinowski, Catalina and Zhao, Hui and Shih, Ya-Chen and Giordano, Sharon H},
  title = {Medicaid expansion, chemotherapy delays, and racial disparities among women with early-stage breast cancer},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2023},
  doi = {10.1093/jnci/djad033}
}
Kostenlos starten →